JP2000505650A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000505650A5 JP2000505650A5 JP1997528715A JP52871597A JP2000505650A5 JP 2000505650 A5 JP2000505650 A5 JP 2000505650A5 JP 1997528715 A JP1997528715 A JP 1997528715A JP 52871597 A JP52871597 A JP 52871597A JP 2000505650 A5 JP2000505650 A5 JP 2000505650A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1143396P | 1996-02-08 | 1996-02-08 | |
| US60/011,433 | 1996-02-08 | ||
| PCT/US1997/002063 WO1997029183A2 (en) | 1996-02-08 | 1997-02-07 | Methods and compositions for transforming dendritic cells and activating t cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000505650A JP2000505650A (ja) | 2000-05-16 |
| JP2000505650A5 true JP2000505650A5 (enExample) | 2004-11-18 |
Family
ID=21750351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9528715A Ceased JP2000505650A (ja) | 1996-02-08 | 1997-02-07 | 樹状突起細胞を形質転換し、そしてｔ細胞を活性化するための方法及び組成物 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0879281B1 (enExample) |
| JP (1) | JP2000505650A (enExample) |
| AT (1) | ATE314462T1 (enExample) |
| AU (1) | AU730537B2 (enExample) |
| CA (1) | CA2245170A1 (enExample) |
| DE (1) | DE69734974D1 (enExample) |
| WO (1) | WO1997029183A2 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0840622A4 (en) * | 1995-07-21 | 2003-01-02 | Aventis Pharma Inc | ADENO-ASSOCIATED VIRUS LIPOSOMES AND THEIR USE FOR THE TRANSFECTION OF DENDRITIC CELLS FOR THE STIMULATION OF SPECIFIC IMMUNITY |
| US7402307B2 (en) | 1998-03-31 | 2008-07-22 | Geron Corporation | Method for identifying and killing cancer cells |
| AU3456099A (en) | 1998-03-31 | 1999-10-18 | Geron Corporation | Methods and compositions for eliciting an immune response to a telomerase antigen |
| US7351546B2 (en) | 1998-09-22 | 2008-04-01 | Becton, Dickinson And Company | Flow cytometric, whole blood dendritic cell immune function assay |
| US6495333B1 (en) | 1998-09-22 | 2002-12-17 | Becton Dickinson And Company | Flow cytometric, whole blood dendritic cell immune function assay |
| AU3755800A (en) * | 1999-03-15 | 2000-10-04 | Introgen Therapeutics, Inc. | Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses |
| EP1046911A1 (en) * | 1999-04-23 | 2000-10-25 | Universiteit van Amsterdam | Methods for identification of proteinaceous substances capable of inducing cellular reactions |
| WO2000073432A2 (en) * | 1999-06-01 | 2000-12-07 | Cornell Research Foundation, Inc. | Activation of dendritic cells to enhance immunity |
| FR2795415B1 (fr) | 1999-06-28 | 2003-09-05 | Roussy Inst Gustave | Compose peptidique derive d'une orf decalee du gene ice |
| CA2309313A1 (en) * | 1999-08-05 | 2001-02-05 | Board Of Trustees Of The University Of Arkansas | Stimulation of the immune response by human dendritic cell manipulation |
| US7988963B1 (en) * | 1999-10-15 | 2011-08-02 | Baylor Research Institute | Use of allogeneic cell lines to load antigen presenting cells to elicit or eliminate immune responses |
| US7541184B2 (en) | 2000-02-24 | 2009-06-02 | Invitrogen Corporation | Activation and expansion of cells |
| US7572631B2 (en) | 2000-02-24 | 2009-08-11 | Invitrogen Corporation | Activation and expansion of T cells |
| US7767202B2 (en) * | 2001-03-16 | 2010-08-03 | The Johns Hopkins University | Modulation of systemic immune responses by transplantation of hematopoietic stem cells transduced with genes encoding antigens and antigen presenting cell regulatory molecules |
| FR2824567B1 (fr) | 2001-05-11 | 2003-08-08 | Inst Nat Sante Rech Med | Procede d'obtention de lymphocytes tr1 regulateurs specifiques d'antigene |
| EP1450828B1 (en) | 2001-08-17 | 2015-04-01 | Roger Williams Hospital | In situ immunization |
| US7955845B2 (en) | 2001-11-20 | 2011-06-07 | Dana Farber Cancer Institute, Inc. | Modified antigen-presenting cells |
| US7498171B2 (en) | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| AU2006249199A1 (en) | 2005-05-12 | 2006-11-23 | Introgen Therapeutics, Inc. | P53 vaccines for the treatment of cancers |
| US20110313229A1 (en) * | 2008-07-24 | 2011-12-22 | Kiminobu Sugaya | Therapy Targeting Cancer Stem Cells |
| US9678061B2 (en) * | 2010-08-06 | 2017-06-13 | Ludwig-Maximilians-Universität München | Identification of T cell target antigens |
| AU2013203832B2 (en) * | 2012-03-13 | 2016-09-15 | Celularity Inc. | Modified erythrocyte precursor cells and uses thereof |
| WO2016145578A1 (en) * | 2015-03-13 | 2016-09-22 | Syz Cell Therapy Co. | Methods of cancer treatment using activated t cells |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
| EP0631618A4 (en) * | 1992-03-04 | 1995-09-27 | Systemix Inc | CULTIVATION OF HEMOPOETIC STEM CELLS AND THEIR GENETOLOGICAL PRODUCTION. |
| EP0563485A1 (en) * | 1992-03-30 | 1993-10-06 | Schering-Plough | In vitro generation of human dendritic cells and uses thereof |
| EP1624068A1 (en) * | 1993-06-01 | 2006-02-08 | Life Technologies Inc. | Genetic immunization with cationic lipids |
| FR2709309B1 (fr) * | 1993-08-25 | 1995-11-10 | Centre Nat Rech Scient | Compositions cellulaires, préparation et utilisations thérapeutiques. |
| DK0765398T3 (da) * | 1994-06-15 | 2003-09-29 | Systemix Inc | Population af celler, der er beriget for myeloide og/eller lymfoide progenitorer og fremgangsmåde til fremstilling og anvendelse deraf |
| EP0840622A4 (en) * | 1995-07-21 | 2003-01-02 | Aventis Pharma Inc | ADENO-ASSOCIATED VIRUS LIPOSOMES AND THEIR USE FOR THE TRANSFECTION OF DENDRITIC CELLS FOR THE STIMULATION OF SPECIFIC IMMUNITY |
-
1997
- 1997-02-07 WO PCT/US1997/002063 patent/WO1997029183A2/en not_active Ceased
- 1997-02-07 DE DE69734974T patent/DE69734974D1/de not_active Expired - Lifetime
- 1997-02-07 EP EP97905877A patent/EP0879281B1/en not_active Expired - Lifetime
- 1997-02-07 AT AT97905877T patent/ATE314462T1/de not_active IP Right Cessation
- 1997-02-07 JP JP9528715A patent/JP2000505650A/ja not_active Ceased
- 1997-02-07 AU AU22660/97A patent/AU730537B2/en not_active Ceased
- 1997-02-07 CA CA002245170A patent/CA2245170A1/en not_active Abandoned